Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia
Biosimilars are safe and effective treatments for chronic diseases such as cancer and rheumatoid arthritis. The Saudi Food and Drug Authority (SFDA) manages the quality and registration of biosimilars in the Kingdom of Saudi Arabia. However, disparities among regulatory authorities, such as the abse...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Minnesota Libraries Publishing
2024-11-01
|
Series: | INNOVATIONS in Pharmacy |
Subjects: | |
Online Access: | https://pubs.lib.umn.edu/index.php/innovations/article/view/6371 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|